Product image of Levetiracetam Stada (Levetiracetam) supplied by GNH India

Levetiracetam Stada

Active Ingredient:
Levetiracetam
Origin:
EU

Levetiracetam Stada (Levetiracetam)

Levetiracetam, the active ingredient in Levetiracetam Stada, is an anticonvulsant presented as a tablet for oral use. It is employed to control partial‑onset, generalized tonic‑clonic and myoclonic seizures in patients with epilepsy through modulation of neuronal excitability.

GNH India supplies Levetiracetam Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory support for cross‑border distribution. Customers benefit from reliable lead times and comprehensive documentation.

Manufacturer / TM Owner

Stada Arzneimittel Ag

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Levetiracetam is an antiepileptic drug used to treat several seizure types.

  • Partial‑onset seizures: reduces the frequency and severity of focal seizures, improving daily functioning.
  • Generalized tonic‑clonic seizures: helps prevent convulsive episodes in generalized epilepsy, decreasing injury risk.
  • Myoclonic seizures: controls sudden muscle jerks associated with myoclonic epilepsy, enhancing quality of life.

How It Works

  • Levetiracetam binds selectively to the synaptic vesicle protein SV2A, a key regulator of neurotransmitter release. This interaction modulates synaptic vesicle exocytosis, stabilizing neuronal firing and reducing hyper‑excitability. By influencing calcium‑dependent release of glutamate and other excitatory transmitters, the drug diminishes the propagation of epileptiform activity without significant effects on ion channels or G‑protein pathways. The precise downstream effects remain under investigation, but the overall result is a net decrease in seizure susceptibility.

Side Effects

Levetiracetam may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Dizziness: transient sensation of light‑headedness or imbalance.
  • Fatigue: persistent feeling of tiredness or reduced energy.
  • Headache: mild to moderate pressure or throbbing pain.
  • Nausea: feeling of queasiness, sometimes leading to vomiting.

Serious or Rare Side Effects

  • Severe allergic reactions (e.g., Stevens‑Johnson syndrome): skin blistering and mucosal involvement.
  • Mood changes including depression or suicidal thoughts: emerging or worsening psychiatric symptoms.
  • Hematologic abnormalities such as neutropenia: reduced white blood cell count increasing infection risk.
  • Hepatic dysfunction: elevated liver enzymes or jaundice indicating liver injury.

Precautions & Warnings

When prescribing Levetiracetam, clinicians should consider several precautionary measures to ensure safe use.

  • Renal impairment: adjust dose based on creatinine clearance.
  • History of psychiatric disorders: monitor for mood changes or depression.
  • Concomitant CNS depressants: assess additive sedation risk.
  • Pregnancy: evaluate risk‑benefit ratio; limited data available.
  • Elderly patients: start at lower dose and titrate cautiously.
  • Store at ambient temperature: keep below 25 °C, protect from moisture in original container.

Avoid Interactions

Levetiracetam can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid)

  • Carbamazepine: may reduce levetiracetam plasma levels.
  • Phenobarbital: can lower levetiracetam exposure.
  • Phenytoin: may decrease levetiracetam concentrations.

Moderate Interactions (Monitor Closely)

  • Alcohol: enhances central nervous system depression.
  • Opioids: may increase sedation when combined.
  • Other antiepileptics (e.g., valproate): monitor for additive side effects.

Frequently Asked Questions

Levetiracetam Stada is prescribed to manage epilepsy. It is indicated for partial‑onset seizures, generalized tonic‑clonic seizures, and myoclonic seizures, helping to reduce seizure frequency and improve overall neurological stability in patients diagnosed with these seizure types.

Levetiracetam exerts its effect by binding to the synaptic vesicle protein SV2A, which regulates neurotransmitter release. This binding modulates vesicle exocytosis, stabilizing neuronal firing and decreasing the hyper‑excitability that underlies seizure activity.

The appropriate dose of Levetiracetam Stada is individualized by the prescribing clinician. Dosage decisions consider factors such as the patient’s age, renal function, seizure type, and response to therapy, and are adjusted during treatment as needed.

Safety data for levetiracetam in pregnancy and lactation are limited. Clinicians should weigh the potential benefits against possible risks, and the drug should only be used if the expected therapeutic advantage justifies exposure. Breastfeeding mothers should consult their healthcare provider for personalized advice.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Levetiracetam offers a distinct mechanism by targeting SV2A, which differs from sodium‑channel blockers or GABA‑enhancers. It is generally well tolerated, has few drug‑enzyme interactions, and does not require routine therapeutic drug monitoring, making it a convenient option compared with many older antiepileptics.

Levetiracetam Stada should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Levetiracetam Stada is administered orally. The tablet is swallowed whole with water, and dosing frequency is determined by the prescriber. It can be taken with or without food, and patients should follow the specific instructions provided by their healthcare professional.

Serious risks include severe allergic reactions such as Stevens‑Johnson syndrome, significant mood alterations including depression or suicidal ideation, hematologic abnormalities like neutropenia, and hepatic dysfunction. Patients should be monitored closely for any of these events and seek immediate medical attention if they occur.

Levetiracetam Stada is contraindicated in individuals with known hypersensitivity to levetiracetam or any of its excipients. Caution is also advised for patients with severe renal impairment, uncontrolled psychiatric conditions, or those taking medications that markedly reduce levetiracetam levels without appropriate dose adjustment.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Levetiracetam

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT